These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2258296)

  • 21. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T; Maekawa S; Morinobu S; Morinobu A; Koshiba M; Yamauchi M; Sugimoto T; Kumagai S
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soft tissue stabilization in the management of chronic scapholunate instability without osteoarthritis. A 15-year series.
    Saffar P; Sokolow C; Duclos L
    Acta Orthop Belg; 1999 Dec; 65(4):424-33. PubMed ID: 10675937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bones and retinoids].
    Zabarino P; Monpoint S
    Ann Dermatol Venereol; 1991; 118(10):745-8. PubMed ID: 1781599
    [No Abstract]   [Full Text] [Related]  

  • 27. Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy.
    Desai A; Kartono F; Del Rosso JQ
    Dermatol Clin; 2007 Apr; 25(2):185-93, vi. PubMed ID: 17430755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
    Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F;
    HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
    Van Dooren-Greebe RJ; Lemmens JA; De Boo T; Hangx NM; Kuijpers AL; Van de Kerkhof PC
    Br J Dermatol; 1996 Jan; 134(1):71-6. PubMed ID: 8745889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fracturing support for the role of systemic retinoid therapy as a cause of bone demineralization.
    DiGiovanna JJ
    Arch Dermatol; 2010 May; 146(5):551-3. PubMed ID: 20479307
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse effects of large doses of vitamin A and retinoids.
    Olson JA
    Semin Oncol; 1983 Sep; 10(3):290-3. PubMed ID: 6364354
    [No Abstract]   [Full Text] [Related]  

  • 33. Arotinoid acid (Ro 13-7410): a pilot study in dermatology.
    Saurat JH; Mérot Y; Borsky M; Abba Z; Hirschel-Scholz S
    Dermatologica; 1988; 176(4):191-9. PubMed ID: 3378655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects and long-term toxicity of synthetic retinoids.
    Yob EH; Pochi PE
    Arch Dermatol; 1987 Oct; 123(10):1375-8. PubMed ID: 3310911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatological symptoms due to retinoids.
    Kaplan G; Haettich B
    Baillieres Clin Rheumatol; 1991 Apr; 5(1):77-97. PubMed ID: 2070429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone changes associated with oral retinoid therapy.
    White SI; MacKie RM
    Pharmacol Ther; 1989; 40(1):137-44. PubMed ID: 2645586
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term safety of retinoid therapy.
    Vahlquist A
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S29-33. PubMed ID: 1460122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vertebral abnormalities associated with synthetic retinoid use.
    Gerber LH; Helfgott RK; Gross EG; Hicks JE; Ellenberg SS; Peck GL
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):817-23. PubMed ID: 6586753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of skeletal changes during short-term acitretin therapy.
    Hohl D; Pelloni F; Sigg C; Gilardi S; Jung T
    Dermatology; 1992; 185(1):23-6. PubMed ID: 1386262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Crowned Dens syndrome: calcification of the transverse ligament of the atlas].
    Peñas Martínez E; Moreno Martínez MJ; Marras Fernandez-Cid C; Torregrosa Sala B
    Reumatol Clin; 2012; 8(1):48-9. PubMed ID: 22089072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.